Published by ChinaMNC · Qilin

Yunnan's 15th Five-Year Plan for Chinese Medicinal Herbs: What Foreign Founders Should Know

Yunnan plans to shrink herb-growing area while raising output value by 2030, shifting toward higher-quality, processed and branded products. Here is a practical breakdown for foreign founders evaluating the sector.

A Different Kind of Growth Target

Foreign founders scanning provincial plans for expansion signals may find Yunnan's approach counterintuitive. By 2030, the province expects the cultivated area for Chinese medicinal herbs to fall by 1.608 million mu, while the target for composite output value rises by 50 billion yuan. The stated logic is to trade planted area for gains in quality, processing, branding and returns. For a foreign founder, the signal is that policy support is tilting toward higher-value segments rather than raw volume.

Which Varieties Are Prioritized

The plan builds on the 156 varieties listed in the 2024 edition of Yunnan's catalog of authentic regional herbs. It groups priorities into three tiers:

• Authentic advantage varieties — the "Top Ten Cloud Herbs," led by sanqi (Panax notoginseng). The full list is sanqi, Yunnan Paris polyphylla, Erigeron breviscapus, Dendrobium officinale, amomum fruit, gastrodia, Yunnan poria, Yunnan angelica, Yunnan costus and Yunnan gentian.
• Health-oriented specialty varieties — the "Top Ten Health Resources": Yunnan polygonatum, safflower, bletilla, purple-skin dendrobium, emblica (Yunnan olive), coix seed, terminalia chebula, tsaoko, ginger and star anise.
• Potential varieties under development — the "Six Southern Medicines": amomum fruit, dragon's blood, cibotium, agarwood, kidney tea and Dai Bai Jie.

Founders sourcing or processing herbs should map their product lines against these lists, since prioritization typically correlates with where provincial support and standardization efforts concentrate.

Standardization: The GAP Push

The plan aims to build 200 Good Agricultural Practice (GAP) bases for medicinal herbs. It specifically targets full GAP coverage for Wenshan sanqi, and orderly development of GAP bases for under-forest varieties including poria, amomum fruit, tsaoko and phellodendron. It also aims to create a set of national-level high-standard raw material production bases.

For foreign-invested enterprises, GAP certification matters because it underpins traceability and quality claims that downstream buyers and regulators increasingly expect.

Under-Forest Cultivation

Focusing on sanqi, gastrodia, poria, amomum fruit, polygonatum and phellodendron, the province plans to expand ecological and under-forest cultivation bases to more than 6 million mu. Under-forest production is presented as a way to combine ecological protection with supply. Founders should note that under-forest sourcing involves different land-use arrangements and traceability trails than field cultivation.

Processing and Value Addition

Two processing layers receive support:

Origin-based primary processing

The plan supports establishing processing lines in authentic herb-producing areas and at high-standard raw material bases. It links GAP-base herbs with fresh-cut processing, and pushes products from raw primary materials toward semi-industrialized input materials.

Deep processing and consumer products

Enterprises are encouraged to build modern deep-processing lines and develop high-value-added products, forming a series of Cloud Herb health products. The plan also promotes R&D and industrialization of health products in categories such as personal care and cosmetics, and functional wellness.

For founders, the clearest opportunity framing in the document sits here: moving from raw material supply into processed inputs and branded consumer health products.

Market Stabilization and Risk Warning

The plan addresses volatility in bulk and scarce varieties such as sanqi, angelica and Paris polyphylla, proposing market-based adjustment to smooth price swings. It also calls for an information monitoring and early-warning system to flag risks such as blind expansion of planting and prices falling so low that growers are harmed.

Foreign founders building supply contracts should treat such mechanisms as context: price volatility in these herbs is officially recognized, and provincial monitoring may affect planting decisions upstream.

Food-Medicine Homology Development

The plan calls for standards covering raw material quality and production and processing norms for food-medicine homology ingredients. It also targets cross-border registration of 5 to 10 new products, and plans a Cloud Herb food-medicine homology culture festival.

The cross-border registration target is worth watching for founders with export or regional distribution ambitions, since registration pathways shape market access.

The "Cloud Herb Brain"

An AI innovation application project called "Cloud Herb Brain" is planned, building an intelligent application system covering the full lifecycle of medicinal herbs. It aims to form multi-level, multi-scenario intelligent solutions in key areas.

Practical Takeaways for Founders

• Position above raw volume. Policy direction favors quality, processing, branding and efficiency over planted area.
• Check variety alignment. Compare your portfolio with the Top Ten Cloud Herbs, Top Ten Health Resources and Six Southern Medicines.
• Plan for GAP. If you source or process herbs, GAP base linkage may become a practical requirement for quality claims.
• Watch standards and registration. Food-medicine homology standards and cross-border registration targets may shape product categories and market access.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.